Hepaglide Semaglutide Injection 0.25 mg Kit

AboutHepaglide 0.25 mg is a semaglutide prefilled injection kit containing a multidose pen, needles and alcohol swabs as supplied. It is used under prescription for approved weight-management or diabetes-related indications, according to local product authorisation.Usage InstructionsInject subcutaneously once weekly on the prescribed day. Use the pen only after receiving training. Do not inject intravenously or intramuscularly, and do not share the pen. Follow the supplied needle and dose-selection instructions.BenefitsMay support gradual dose initiation, blood glucose control or weight management depending on the approved indication.How it WorksSemaglutide activates GLP-1 receptors, increasing glucose-dependent insulin release, reducing inappropriate glucagon secretion, slowing gastric emptying and reducing appetite.Side EffectsNausea, vomiting, diarrhoea, constipation, abdominal pain, reduced appetite and injection-site reactions may occur. Seek urgent care for severe persistent abdominal pain, dehydration, repeated vomiting, gallbladder symptoms or allergy.Safety AdvicePrescription use only. Do not use in pregnancy unless specifically directed. Tell the doctor about pancreatitis, gallbladder disease, kidney disease, diabetic eye disease, severe gastrointestinal disease and other diabetes medicines. Follow the escalation schedule; do not increase the dose yourself.StorageStore unopened pens at 2°C to 8°C. Do not freeze or shake. Protect from light. Follow the pack’s in-use storage period after first use and maintain the cold chain during transport.